Office of National Drug Control Policy

Freedom of Information Act Requests (FOIA)

Improving Disclosure of Information Summary

Public Liaison: Michael Passante, (202) 395-6622
FOIA Requestor Center: Sandy Slater, (202) 395-6622

Chief FOIA Officer:   Michael Passante, (202) 395-6622

How to Make a FOIA Request to the ONDCP

A request made under the FOIA must be submitted in writing, by mail or fax, to the following address:

Office of Legal Counsel
Attn:  Chief FOIA Officer
750 17th Street, N.W.

Washington, D.C.  20503
Phone: (202) 395-6622
Fax: (202) 395-5543

Quarterly FOIA Reports

Archived FOIA Reports    

Chief FOIA Officer’s Report


Pursuant to the Federal Activities Inventory Reform Act (FAIR), be advised that the Office of National Drug Control Policy (ONDCP) does not perform any commercial activities by in-house employees.

Information Quality Guidelines

The Office of National Drug Control Policy publishes these guidelines in accordance with the Guidelines for Ensuring and Maximizing the Quality, Objectivity, Utility, and Integrity of Information disseminated by Federal Agencies (Government-wide guidelines) published in interim final form by OMB in the Federal Register in Volume 66, No. 189 at 49718 on Friday, September 8, 2001, and in final form in Volume 2, No. 67 at 8452 on February 2, 2002.

Guide to Unsolicited Proposals

ONDCP strongly encourages potential offerors to participate in the preliminary process before expending time or money preparing an Unsolicited Proposal.

Ethics Policies

  • Public Financial Disclosure (SF 278) Process
  • Confidential Financial Disclosure Report (SF 450) Process


Historically, ONDCP has rarely declassified documents.  However, ONDCP recently began declassifying documents related to drug issues that were created in the mid to late 1980s when ONDCP was created as an agency.  To obtain declassified documents, please submit a request to the National Archives and Records Administration (NARA) at  ONDCP follows declassification policies and procedures established by NARA at  Furthermore, ONDCP has a policy allowing staff members to challenge classifications that can be found here.

For additional questions regarding FOIA, please visit the contact us page.

Neither ONDCP nor its Director and staff endorse any commercial drug control product.

Attached File(s):